Stabilization mechanism of amorphous carbamazepine by transglycosylated rutin, a non-polymeric amorphous additive with a high glass transition temperature.

Amorphous formulation Differential scanning calorimetry Drug-excipient interaction Simulation Solid-state nuclear magnetic resonance spectroscopy

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
01 May 2021
Historique:
received: 15 12 2020
revised: 24 02 2021
accepted: 10 03 2021
pubmed: 22 3 2021
medline: 22 6 2021
entrez: 21 3 2021
Statut: ppublish

Résumé

α-Glycosyl rutin (Rutin-G), composed of a flavonol skeleton and sugar groups, is a promising non-polymeric additive for stabilizing amorphous drug formulations. In this study, the mechanism of the stabilization of the amorphous state of carbamazepine (CBZ) by Rutin-G was investigated. In comparison with hypromellose (HPMC), which is commonly used as a crystallization inhibitor for amorphous drugs, Rutin-G significantly stabilized amorphous CBZ. Moreover, the dissolution rate and the resultant supersaturation level of CBZ were significantly improved in the CBZ/Rutin-G spray-dried samples (SPDs) owing to the rapid dissolution property of Rutin-G. Differential scanning calorimetry measurement demonstrated a high glass transition temperature (T

Identifiants

pubmed: 33744450
pii: S0378-5173(21)00296-9
doi: 10.1016/j.ijpharm.2021.120491
pii:
doi:

Substances chimiques

Carbamazepine 33CM23913M
Hypromellose Derivatives 3NXW29V3WO
Rutin 5G06TVY3R7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120491

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Chisa Aoki (C)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Xiaohan Ma (X)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Kenjirou Higashi (K)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. Electronic address: ken-h@faculty.chiba-u.jp.

Yuya Ishizuka (Y)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Keisuke Ueda (K)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Kazunori Kadota (K)

Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.

Kaori Fukuzawa (K)

School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.

Yuichi Tozuka (Y)

Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.

Kohsaku Kawakami (K)

International Center for Materials Nanoarchitectonics, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan.

Etsuo Yonemochi (E)

School of Pharmacy and Pharmaceutical Sciences, Hoshi University, 2-4-41, Ebara, Shinagawa, Tokyo 142-8501, Japan.

Kunikazu Moribe (K)

Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

Articles similaires

Inclusion Bodies Solubility Recombinant Proteins Detergents Protein Denaturation

Elucidating ATP's role as solubilizer of biomolecular aggregate.

Susmita Sarkar, Saurabh Gupta, Chiranjit Mahato et al.
1.00
Adenosine Triphosphate Protein Aggregates Solubility Humans Protein Conformation

Comparative assessment of physics-based in silico methods to calculate relative solubilities.

Adiran Garaizar Suarez, Andreas H Göller, Michael E Beck et al.
1.00
Solvents Solubility Quantum Theory Molecular Dynamics Simulation Thermodynamics
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility

Classifications MeSH